Denise Siegrist

Spiez, BE 3177, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Immune Response after Vaccination against Tick-Borne Encephalitis Virus (TBEV) in Horses.

Immune Response after Vaccination against Tick-Borne Encephalitis Virus (TBEV) in Horses.

Journal: Vaccines

Published: August 10, 2024

Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia.

Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia.

Journal: Pharmaceutics

Published: July 30, 2024

Third-generation smallpox vaccines induce low-level cross-protecting neutralizing antibodies against Monkeypox virus in laboratory workers.

Third-generation smallpox vaccines induce low-level cross-protecting neutralizing antibodies against Monkeypox virus in laboratory workers.

Journal: Heliyon

Published: February 26, 2024

Presence and Persistence of Andes Virus RNA in Human Semen.

Presence and Persistence of Andes Virus RNA in Human Semen.

Journal: Viruses

Published: October 20, 2023

Virucidal activity of three standard chemical disinfectants against Ebola virus suspended in tripartite soil and whole blood.

Virucidal activity of three standard chemical disinfectants against Ebola virus suspended in tripartite soil and whole blood.

Journal: Scientific reports

Published: January 20, 2023

Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro.

Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 19, 2022

68/f-Progressive dyspnea on exertion and petechiae : Preparation for the medical specialist examination: part 43

68/f-Progressive dyspnea on exertion and petechiae : Preparation for the medical specialist examination: part 43

Journal: Der Internist

Published: February 17, 2021

Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults.

Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults.

Journal: Viruses

Published: January 22, 2021

Author Correction: In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.

Author Correction: In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.

Journal: Virology journal

Published: November 10, 2020

Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation study.

Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation study.

Journal: Allergy

Published: August 03, 2020

Social Distancing Alters the Clinical Course of COVID-19 in Young Adults: A Comparative Cohort Study.

Social Distancing Alters the Clinical Course of COVID-19 in Young Adults: A Comparative Cohort Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 04, 2020

In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.

In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.

Journal: Virology journal

Published: February 27, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026